The Enterprise Value as of November 2025 (TTM) for Promore Pharma AB (publ) (PROMO.ST) is 276.45M

According to Promore Pharma AB (publ)’s latest financial reports and current stock price. The company's current Enterprise Value is 276.45M. This represents a change of -94.15% compared to the average of 4.73B of the last 4 quarters.

Promore Pharma AB (publ) (PROMO.ST) Historical Enterprise Value (quarterly & annually)

How has PROMO.ST Enterprise Value performed in the past?

The mean historical Enterprise Value of Promore Pharma AB (publ) over the last ten years is 15.04B. The current 276.45M Enterprise Value has changed 83.75% with respect to the historical average. Over the past ten years (40 quarters), PROMO.ST's Enterprise Value was at its highest in in the June 2018 quarter at 41.38B. The Enterprise Value was at its lowest in in the March 2016 quarter at 0.

Promore Pharma AB (publ) (PROMO.ST) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Promore Pharma AB (publ) Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Promore Pharma AB (publ) (PROMO.ST) Average Enterprise Value

How has PROMO.ST Enterprise Value performed in the past?

The current Enterprise Value of Promore Pharma AB (publ) (PROMO.ST) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Promore Pharma AB (publ) (PROMO.ST) Enterprise Value vs. Peers

How is PROMO.ST’s Enterprise Value compared to its peers?

Promore Pharma AB (publ)’s Enterprise Value is less than Medivir AB (publ) (411.40M), greater than ISR Immune System Regulation Holding AB (publ) (42.87M), greater than Idogen AB (publ) (7.48M), greater than Asarina Pharma AB (publ) (-1527041.00), greater than Pharmiva AB (publ) (-1197289.00), greater than Kancera AB (publ) (8.45M), greater than Ziccum AB (publ) (7.88M), greater than Cyxone AB (publ) (-9918956.00), greater than Medhelp Care Aktiebolag (publ) (204.73M), greater than Scandion Oncology A/S (-11962272.60),

Build a custom stock screener for Promore Pharma AB (publ) (PROMO.ST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Promore Pharma AB (publ) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Promore Pharma AB (publ) (PROMO.ST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Promore Pharma AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.